BRPI0509221A - epothilone and carboplatin combination therapies - Google Patents

epothilone and carboplatin combination therapies

Info

Publication number
BRPI0509221A
BRPI0509221A BRPI0509221-3A BRPI0509221A BRPI0509221A BR PI0509221 A BRPI0509221 A BR PI0509221A BR PI0509221 A BRPI0509221 A BR PI0509221A BR PI0509221 A BRPI0509221 A BR PI0509221A
Authority
BR
Brazil
Prior art keywords
epothilone
combination therapies
carboplatin
carboplatin combination
therapies
Prior art date
Application number
BRPI0509221-3A
Other languages
Portuguese (pt)
Inventor
Yiqing Zhou
Robert G Johnson Jr
Original Assignee
Kosan Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/088,534 external-priority patent/US20050215604A1/en
Application filed by Kosan Biosciences Inc filed Critical Kosan Biosciences Inc
Publication of BRPI0509221A publication Critical patent/BRPI0509221A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"TERAPIAS DE COMBINAçãO COM EPOTILONAS E CARBOPLATINA. A presente invenção refere-se a uma terapia de combinação de uma epotilona e uma carboplatina que é eficaz para tratar tumores.EPOTILONE AND CARBOPLATIN COMBINATION THERAPIES. The present invention relates to a combination therapy of an epothilone and a carboplatin that is effective for treating tumors.

BRPI0509221-3A 2004-03-26 2005-03-24 epothilone and carboplatin combination therapies BRPI0509221A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55385604P 2004-03-26 2004-03-26
US11/088,534 US20050215604A1 (en) 2004-03-26 2005-03-23 Combination therapies with epothilones and carboplatin
PCT/US2005/009657 WO2005098027A1 (en) 2004-03-26 2005-03-24 Combination therapies with epothilones and carboplatin

Publications (1)

Publication Number Publication Date
BRPI0509221A true BRPI0509221A (en) 2007-09-04

Family

ID=38442539

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509221-3A BRPI0509221A (en) 2004-03-26 2005-03-24 epothilone and carboplatin combination therapies

Country Status (1)

Country Link
BR (1) BRPI0509221A (en)

Similar Documents

Publication Publication Date Title
CY1112387T1 (en) THERAPEUTIC COMPOSITION CONTAINING TOULAHISTON A PRODUCER OF PYRROLOVENZODIAZEPIN AND FLUDARABIN
ECSP067043A (en) USEFUL PIRROLOTRIAZINE DERIVATIVES TO TREAT HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS
MA33974B1 (en) COMBINATIONS OF A PI3K INHIBITOR AND A MEK INHIBITOR
CY1109551T1 (en) PROTECTIVE SUSPENSIONS AND METHODS OF USING THESE
BR112015026021A2 (en) combination therapy comprising a tor kinase inhibitor and n- (3- (5-fluoro-2- (4- (2-methoxyethoxy) phenylamino) pyrimidin-4-ylamino) phenyl) acrylamide for cancer treatment
BRPI0516954A (en) c-aryl glycoside sgl t2 inhibitors and method
MY174080A (en) Use of dpp iv inhibitors
CY1109985T1 (en) PROTESTOUS SUSPENSIONS AND METHODS OF USING THESE
BR112015026297A2 (en) combination therapy consisting of a tor kinase inhibitor and a substituted 5-quinazolinone compound for cancer treatment
BRPI0414794A (en) substituted oxadiazolidinediones
CR11486A (en) TREATMENT OF UTERINE CANCER AND OVARIO CANCER WITH A PARP INHIBITOR ONLY OR IN COMBINATION WITH ANTI-TUMOR AGENTS
BRPI0518315B8 (en) thiazole compounds that modulate hsp90 protein activity, associated methods of inhibition, treatment and induction, and pharmaceutical composition
TR201900306T4 (en) Methods of using Mek inhibitors.
BR0017075A (en) Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease
AR044007A1 (en) METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE
BRPI0514549A (en) pyrrol-naphthyl acids as inhibitors of pai-1
MX2019002996A (en) Nanoparticles as catalytic substrates for real-time biosensing of human performance and diagnostic and therapeutic methods.
BRPI0408063A (en) methods and compositions involving mda-7
BRPI0508333A (en) use of a vitamin d compound, method of preventing and / or treating interstitial cystitis, pharmaceutical formulation, vitamin d compound, and kit
CR10139A (en) "COMBINATION OF AN ACETILCOLINESTERASE INHIBITOR AND A 5-HT6 ANTAGONIST FOR THE TREATMENT OF CONGNITIVE DISFUSION"
BR112015026247A2 (en) methods for cancer treatment using tor kinase inhibitor combination therapy
BR112014019399A2 (en) fibrosis treatment methods
BR0313470A (en) Therapeutic combinations of erbb kinase inhibitors and antineoplastic therapies
WO2006081371A3 (en) Combination therapy with triterpenoid compounds and proteasome inhibitors
BRPI0411347A (en) therapeutic combinations comprising pde inhibitors and vasopressin receptor antagonists for the treatment of dysmenorrhea

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.